RCT of Duloxetine and Pregabalin for the Treatment of Gulf War Illness in Veterans
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2019
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Headache; Pain
- Focus Adverse reactions
- Acronyms REGIONS
- 24 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2018 Planned number of patients changed from 180 to 162.
- 31 Mar 2017 Planned End Date changed from 1 Jul 2020 to 1 Jan 2021.